DNA

#2377
Ginkgo Bioworks Holdings, Inc. Class A Common Stock
9.5 6 USD
+2.47%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
9.50
9.75
Yıllık Aralık
5.37
10.64
Günlük Değişim
+2.47%
Aylık Değişim
+27.21%
6 Aylık Değişim
+7.66%
Yıllık Değişim
+7.66%
Önceki Kapanış
9.3 3
Open
9.5 9
Düşük
9.5 0
High
9.7 5
Hacim
204
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
Gelir tablosu Bilanço Nakit akışı
Değer 20212022202320242025 TTM

Ginkgo Bioworks Holdings, Inc. Class A Common Stock

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Haberler